Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis
- 1 June 1999
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 97 (1-2) , 110-118
- https://doi.org/10.1016/s0165-5728(99)00064-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus-induced demyelinating diseaseInternational Immunology, 1997
- Increases in soluble VCAM‐1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β‐1bAnnals of Neurology, 1997
- Recovery phase of acute experimental autoimmune encephalomyelitis in rats corresponds to development of endothelial cell unresponsiveness to interferon gamma activationJournal of Neuroscience Research, 1996
- Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitisJournal of Neuroimmunology, 1994
- Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM‐1Annals of Neurology, 1993
- Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 1993
- Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.The Journal of Experimental Medicine, 1993
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1Science, 1992
- Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system.The Journal of Experimental Medicine, 1990